Parc de Salut Mar

Quick facts

Marketed products

• Inhaled Corticosteroids (ICs) · Respiratory/Pulmonology
  Inhaled corticosteroids reduce airway inflammation by binding to glucocorticoid receptors in lung tissue, suppressing inflammatory cytokine production and immune cell activation.
• Oral strogen
• Polyethylene glycol + ascorbate · Gastroenterology
  Polyethylene glycol with ascorbate acts as an osmotic laxative that draws water into the intestinal lumen while ascorbate enhances bowel cleansing efficacy.
• Sodium picosulfate + magnesium citrate · Gastroenterology
  Sodium picosulfate acts as a stimulant laxative that increases intestinal motility, while magnesium citrate provides osmotic laxative effect to draw water into the bowel, together producing bowel evacuation.
• Transdermal strogen · Endocrinology / Women's Health
  Transdermal estrogen delivers estradiol through the skin to replace or supplement endogenous estrogen levels.

Phase 3 pipeline

• PEG 4L
  PEG 4L is a polyethylene glycol used as a solubilizing agent in pharmaceutical formulations.
• PEG-ascorbate 2L · Oncology
  PEG-ascorbate 2L is a polyethylene glycol-conjugated form of vitamin C designed to improve systemic delivery and bioavailability of ascorbate for antioxidant and potential anti-cancer effects.

Phase 2 pipeline

• Inhaler device
• Other treatments
• Pain-Relief Medication

Phase 1 pipeline

• Mephedrone and alcohol
• Oxycodone IN
• Testosterone cyclopentylpropionate
• Zolmitriptan intranasal.
• Zolmitriptan oral.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Parc de Salut Mar portfolio CI brief
• Parc de Salut Mar pipeline updates RSS